Troponine I versus Creatinine Kinase-MB as Predictor Markers of the Severity and Outcomes in Acute Theophylline Toxicity
Hodeib, A., Ghonem, M. (2019). Troponine I versus Creatinine Kinase-MB as Predictor Markers of the Severity and Outcomes in Acute Theophylline Toxicity. EKB Journal Management System, 27(2), 57-72. doi: 10.21608/mjfmct.2019.52476
Aliaa A. Hodeib; Mona M. Ghonem. "Troponine I versus Creatinine Kinase-MB as Predictor Markers of the Severity and Outcomes in Acute Theophylline Toxicity". EKB Journal Management System, 27, 2, 2019, 57-72. doi: 10.21608/mjfmct.2019.52476
Hodeib, A., Ghonem, M. (2019). 'Troponine I versus Creatinine Kinase-MB as Predictor Markers of the Severity and Outcomes in Acute Theophylline Toxicity', EKB Journal Management System, 27(2), pp. 57-72. doi: 10.21608/mjfmct.2019.52476
Hodeib, A., Ghonem, M. Troponine I versus Creatinine Kinase-MB as Predictor Markers of the Severity and Outcomes in Acute Theophylline Toxicity. EKB Journal Management System, 2019; 27(2): 57-72. doi: 10.21608/mjfmct.2019.52476

Troponine I versus Creatinine Kinase-MB as Predictor Markers of the Severity and Outcomes in Acute Theophylline Toxicity

Mansoura Journal of Forensic Medicine and Clinical Toxicology
Article 5, Volume 27, Issue 2, July 2019, Page 57-72  XML PDF (448.49 K)
Document Type: Original Article
DOI: 10.21608/mjfmct.2019.52476
View on SCiNiTO View on SCiNiTO
Authors
Aliaa A. Hodeib; Mona M. Ghonem
Forensic Medicine and Clinical Toxicology Department, Faculty of Medicine, Tanta University.
Abstract
Theophylline is a bronchodilator drug that is used in the treatment of asthma and chronic obstructive pulmonary diseases. Cardiovascular complications contribute to morbidity and mortality that associate acute theophylline intoxication. The current study aimed to investigate troponin I and creatine kinase-MB as predictors of the severity and outcomes in cases of acute theophylline intoxication. This prospective cohort study included thirty one patients with acute theophylline toxicity admitted to Tanta Poison Control Center during the period from the first of March 2018 to the end of February 2019. Patients were subjected to personal and toxicological history taking, vital signs collection, grading of acute theophylline toxicity and measurement of serum theophylline level. Both troponin I and creatine kinase-MB were measured at admission and 12 hours post admission. Results revealed that, troponin I at time of admission and 12 hours post admission in addition to creatine kinase-MB 12 hours post admission were significantly higher in cases with severe acute theophylline intoxication and patients who required intensive care unit admission. It was concluded that, troponin I could predict the severity and the requirement of intensive care unit admission in acute theophylline toxicity either with early or delayed presentation. On the other hand, creatine kinase-MB could be considered for patients with delayed presentation.
Keywords
Theophylline; Acute poisoning; troponin I; Creatine kinase-MB; Cardiac damage
Statistics
Article View: 304
PDF Download: 437